Skip to content

Clinical trials

Phase 1/2 Myelodysplastic Syndromes trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1/2 Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20121
20131
20143
20161
20171
20181
20201
20212
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Terminated3
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bellicum Pharmaceuticals2
AstraZeneca1
BeOne Medicines1
BerGenBio ASA1
Constellation Pharmaceuticals1
Curis, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Forma Therapeutics, Inc.1
Gamida Cell ltd1
Groupe Francophone des Myelodysplasies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes16
Leukemia, Myeloid, Acute13
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Leukemia4
Anemia3
Hematologic Neoplasms3
Lymphoma, Non-Hodgkin3
Anemia, Aplastic2
Anemia, Diamond-Blackfan2
Anemia, Sickle Cell2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.